Title:
【発明の名称】選択的β▲下3▼-アドレナリン作動剤
Document Type and Number:
Japanese Patent JPH11513376
Kind Code:
A
Abstract:
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a patient in need thereof compounds of the Formula I:
Inventors:
Bell, Michael Gee
Crowell, Thomas A.
Ebrad, Deborah A.
Matthews, Donald Pea
McDonald's, John H. The Third
Rito, Christopher Jay
Anthony Jay, Shoeker
Mark Aye, Winter
Crowell, Thomas A.
Ebrad, Deborah A.
Matthews, Donald Pea
McDonald's, John H. The Third
Rito, Christopher Jay
Anthony Jay, Shoeker
Mark Aye, Winter
Application Number:
JP51292097A
Publication Date:
November 16, 1999
Filing Date:
September 20, 1996
Export Citation:
Assignee:
ELI LILLY AND COMPANY
International Classes:
A61K31/00; A61K31/145; A61K31/165; A61K31/166; A61K31/167; A61K31/18; A61K31/195; A61K31/196; A61K31/215; A61K31/216; A61K31/496; A61K31/50; A61K31/502; A61P3/00; A61K31/495; A61P3/04; A61P3/10; C07C213/02; C07C217/32; C07C217/34; C07C233/25; C07C233/52; C07C235/42; C07C235/66; C07C237/30; C07C255/54; C07C255/58; C07C311/08; C07C323/25; C07C323/63; C07D213/643; C07D213/82; C07D255/04; C07D257/04; C07D295/18; C07D295/192; C07D333/34; C07D213/64; (IPC1-7): C07C217/34; A61K31/00; A61K31/145; A61K31/165; A61K31/18; A61K31/195; A61K31/215; A61K31/495; A61K31/50; C07C213/02; C07C233/25; C07C237/30; C07C311/08; C07C323/25
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)